Levothyroxine - Revision history

Danbot: Switch SMW query from broadtable to table format for better layout with TOC

2026-03-20T21:57:46Z

Switch SMW query from broadtable to table format for better layout with TOC

← Older revision		Revision as of 21:57, 20 March 2026
Line 57:		Line 57:
	\|?Has Route=Route		\|?Has Route=Route
	\|?Has Population=Population		\|?Has Population=Population
	\|format=~~broadtable~~		\|format=table
	\|headers=plain		\|headers=plain
	\|mainlabel=-		\|mainlabel=-

Danbot: Fix SMW query: replace link=subject with mainlabel=- to fix broken subobject fragment links

2026-03-20T17:26:16Z

Fix SMW query: replace link=subject with mainlabel=- to fix broken subobject fragment links

← Older revision		Revision as of 17:26, 20 March 2026
Line 59:		Line 59:
	\|format=broadtable		\|format=broadtable
	\|headers=plain		\|headers=plain
	\|~~link~~=~~subject~~		\|mainlabel=-
	\|sort=Has Indication		\|sort=Has Indication
	\|limit=50		\|limit=50

Danbot: Add dynamic SMW Indications by Condition table (auto-populated from disease pages via MedicationDose template)

2026-03-20T16:44:26Z

Add dynamic SMW Indications by Condition table (auto-populated from disease pages via MedicationDose template)

← Older revision		Revision as of 16:44, 20 March 2026
Line 46:		Line 46:

	==Comments==		==Comments==


			==Indications by Condition==
			''The following table is automatically generated from disease/condition pages across WikEM.''

			{{#ask:[[Has DrugName::Levothyroxine]]
			\|?Has Indication=Indication
			\|?Has Dose=Dose
			\|?Has Context=Context
			\|?Has Route=Route
			\|?Has Population=Population
			\|format=broadtable
			\|headers=plain
			\|link=subject
			\|sort=Has Indication
			\|limit=50
			}}

	==See Also==		==See Also==

ClaireLewis at 22:54, 22 September 2019

2019-09-22T22:54:47Z

← Older revision		Revision as of 22:54, 22 September 2019
Line 1:		Line 1:
	==Administration==		==Administration==
	*Type: Endocrine		*Type: Endocrine, synthetic hormone
	*Dosage Forms: Tablet 13mcg, 25mcg, 50mcg, 75mcg, 88mcg, 100mcg, 112mcg, 125mcg, 137mcg, 150mcg, 175mcg, 200mcg. IV 100mcg, 200mcg, 500mcg		*Dosage Forms: Tablet 13mcg, 25mcg, 50mcg, 75mcg, 88mcg, 100mcg, 112mcg, 125mcg, 137mcg, 150mcg, 175mcg, 200mcg. IV 100mcg, 200mcg, 500mcg
	*Routes of Administration: PO, IV		*Routes of Administration: PO, IV
Line 53:		Line 53:
	<references/>		<references/>
	[[Category:Pharmacology]]		[[Category:Pharmacology]]
			[[Category:Endocrinology]]

Bmurray990: /* Administration */

2019-01-26T21:22:08Z

Administration

← Older revision		Revision as of 21:22, 26 January 2019
Line 1:		Line 1:
	==Administration==		==Administration==
	*Type: Endocrine		*Type: Endocrine
	*Dosage Forms:		*Dosage Forms: Tablet 13mcg, 25mcg, 50mcg, 75mcg, 88mcg, 100mcg, 112mcg, 125mcg, 137mcg, 150mcg, 175mcg, 200mcg. IV 100mcg, 200mcg, 500mcg
	*Routes of Administration: PO, IV		*Routes of Administration: PO, IV
	*Common Trade Names: Synthroid		*Common Trade Names: Synthroid

ClaireLewis: /* Mechanism of Action */

2016-12-26T22:03:59Z

Mechanism of Action

← Older revision		Revision as of 22:03, 26 December 2016
Line 43:		Line 43:

	==Mechanism of Action==		==Mechanism of Action==
	*Synthetic thyroid hormone (T3)		*Synthetic thyroid hormone (T4)

	==Comments==		==Comments==

ClaireLewis: Created page with "==Administration== Type: Endocrine Dosage Forms: Routes of Administration: PO, IV Common Trade Names: Synthroid ==Adult Dosing== *Myxedema coma: 300-500 mcg IV x1, th..."

2016-12-26T22:02:05Z

Created page with "==Administration== *Type: Endocrine *Dosage Forms: *Routes of Administration: PO, IV *Common Trade Names: Synthroid ==Adult Dosing== *Myxedema coma: 300-500 mcg IV x1, th..."

New page

==Administration==
*Type: Endocrine
*Dosage Forms:
*Routes of Administration: PO, IV
*Common Trade Names: Synthroid

==Adult Dosing==
*[[Myxedema coma]]: 300-500 mcg IV x1, then 50-100mcg IV daily until able to tolerate PO
*[[Hypothyroidism]]: doses vary

==Pediatric Dosing==
*[[Hypothyroid]]: Doses vary, 1.7-15 mcg/kg/day PO

==Special Populations==
*[[Drug Ratings in Pregnancy|Pregnancy Rating]]: A
*[[Lactation risk categories|Lactation risk]]: Infant risk minimal
*Renal dosing: Not defined
*Hepatic dosing: Not defined

==Contraindications==
*Allergy to class/drug, hypersensitivity to glycerol
*Uncorrected adrenal insufficiency (may precipitate acute adrenal crisis)
*Acute MI
*Subclinical or overt thyrotoxicosis, nontoxic diffuse goiter, nodular thyroid disease

==Adverse Reactions==
===Serious===
*MI, heart failure, tachycardia, cardiac arrest
*Pseudotumor, seizure
*Dyspnea
*Hyperthyroid
*Decreased bone mineral density, hip fracture
===Common===
*Palpitations
*Diarrhea
*Anxiety, insomnia, fatigue, sweating, weight loss
*Alopecia

==Pharmacology==
*Half-life: 6-7 days
*Metabolism: Hepatic
*Excretion: Renal, fecal

==Mechanism of Action==
*Synthetic thyroid hormone (T3)

==Comments==

==See Also==
*[[Hypothyroidism]], [[Myxedema coma]]

==References==
<references/>
[[Category:Pharmacology]]